Results 31 to 40 of about 4,182 (143)

Antisense technology as a potential strategy for the treatment of coronaviruses infection: With focus on COVID‐19

IET Nanobiotechnology, Volume 16, Issue 3, Page 67-77, May 2022., 2022
Abstract After the outbreak of coronavirus disease 2019 (COVID‐19) in December 2019 and the increasing number of SARS‐CoV‐2 infections all over the world, researchers are struggling to investigate effective therapeutic strategies for the treatment of this infection.
Seyedeh Hoda Alavizadeh, Maham Doagooyan, Fatemeh Zahedipour, Shima Yahoo Torghabe, Bahare Baharieh, Firooze Soleymani, Fatemeh Gheybi   +6 more
wiley   +1 more source

Novel corona virus (COVID-19); Global efforts and effective investigational medicines: A review

Journal of Infection and Public Health, 2021
Coronavirus disease-2019 (COVID-19), associated with the outbreak of deadly virus originating in Wuhan, China, is now a global health emergency and a matter of serious concern.
Madhusudan Goyal, Nisha Tewatia, Hemlata Vashisht, Reena Jain, Sudershan Kumar   +4 more
doaj   +1 more source

COVID-19: Characteristics and Therapeutics

Cells, 2021
Novel coronavirus (COVID-19 or 2019-nCoV or SARS-CoV-2), which suddenly emerged in December 2019 is still haunting the entire human race and has affected not only the healthcare system but also the global socioeconomic balances.
Rameswari Chilamakuri, Saurabh Agarwal
doaj   +1 more source

RETRACTED: Psychological effects of the COVID‐19 pandemic: Perceived stress, anxiety, work–family imbalance, and coping strategies among healthcare professionals in Khartoum state hospitals, Sudan, 2021

Brain and Behavior, Volume 11, Issue 8, August 2021., 2021
This paper has laid sight and yielded good data that should aid in finding correlations between healthcare profession spectrums and stress levels, as well as providing recommendations that may remarkably decrease the consequences of the pandemic on healthcare professionals and the healthcare system. Abstract Background The 2019 novel coronavirus (COVID‐
Ibrahim M. Mahgoub, Amani Abdelrahman, Tibyan A. Abdallah, Khabab Abbasher Hussien Mohamed Ahmed, Mohammed Eltahier Abdalla Omer, ElMuiz Abdelrahman, Zeinab Mohammed Amara Salih   +6 more
wiley   +1 more source

Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: An exploratory clinical trial

Clinical and Translational Medicine, Volume 11, Issue 2, February 2021., 2021
Menstrual blood‐derived MSC transplantation significantly lowers the mortality of severe and critical SARS‐CoV‐2‐induced COVID‐19. This prospective and systematic report assessed the ability of menstrual blood‐derived MSCs to treat both severe and critically ill COVID‐19 patients.
Xiaowei Xu, Wanli Jiang, Lijun Chen, Zhenyu Xu, Qiang Zhang, Mengfei Zhu, Peng Ye, Hang Li, Liang Yu, Xiaoyang Zhou, Chenliang Zhou, Xiaobei Chen, Xiaoqin Zheng, Kaijin Xu, Hongliu Cai, Shufa Zheng, Wubian Jiang, Xiaojun Wu, Dong Li, Lu Chen, Qingqing Luo, Yingyan Wang, Jingjing Qu, Yifei Li, Wendi Zheng, Yingan Jiang, Lingling Tang, Charlie Xiang, Lanjuan Li   +28 more
wiley   +1 more source

Neutralizing Activity and SARS-CoV-2 Vaccine mRNA Persistence in Serum and Breastmilk After BNT162b2 Vaccination in Lactating Women

Frontiers in Immunology, 2022
BackgroundThere is limited information on the functional neutralizing capabilities of breastmilk SARS-CoV-2-specific antibodies and the potential adulteration of breastmilk with vaccine mRNA after SARS-CoV-2 mRNA vaccination.MethodsWe conducted a ...
Kee Thai Yeo, Kee Thai Yeo, Kee Thai Yeo, Wan Ni Chia, Chee Wah Tan, Chengsi Ong, Chengsi Ong, Joo Guan Yeo, Joo Guan Yeo, Joo Guan Yeo, Jinyan Zhang, Su Li Poh, Amanda Jin Mei Lim, Kirsten Hui Zhi Sim, Nursyuhadah Sutamam, Camillus Jian Hui Chua, Salvatore Albani, Salvatore Albani, Lin-Fa Wang, Lin-Fa Wang, Mei Chien Chua, Mei Chien Chua, Mei Chien Chua, Mei Chien Chua   +23 more
doaj   +1 more source

Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine

Frontiers in Oncology, 2023
Patients affected by myelofibrosis (MF) or polycythemia vera (PV) and treated with ruxolitinib are at high risk for severe coronavirus disease 2019. Now a vaccine against the virus SARS-CoV-2, which is responsible for this disease, is available. However,
Giuseppe A. Palumbo, Daniela Cambria, Enrico La Spina, Andrea Duminuco, Antonio Laneri, Anna Longo, Calogero Vetro, Sebastiano Giallongo, Alessandra Romano, Francesco Di Raimondo, Daniele Tibullo, Cesarina Giallongo   +11 more
doaj   +1 more source

Safety and Adverse Events Related to COVID-19 mRNA Vaccines; a Systematic Review

Archives of Academic Emergency Medicine, 2022
Introduction: Knowledge of vaccine-related adverse events is crucial as they are among the most ‎important factors ‎that cause hesitation in receiving vaccines.
SeyedAhmad SeyedAlinaghi, Amirali Karimi, Zahra Pashaei, Arian Afzalian, Pegah Mirzapour, Kobra Ghorbanzadeh, Afsaneh Ghasemzadeh, Mohsen Dashti, Newsha Nazarian, Farzin Vahedi, Marcarious Tantuoyir, Ahmadreza Shamsabadi, Omid Dadras, Esmaeil Mehraeen   +13 more
doaj   +1 more source

Anti-SARS-CoV-2 spike antibody response to the third dose of BNT162b2 mRNA COVID-19 vaccine and associated factors in Japanese hemodialysis patients [PDF]

Kidney Research and Clinical Practice
Background We assessed the anti-SARS-CoV-2 spike antibody response to the third dose of BNT162b2 mRNA COVID-19 vaccine in Japanese hemodialysis patients and determined factors associated with the anti-SARS-CoV-2 spike antibody titer after the third dose ...
Keiji Hirai, Masako Shimotashiro, Toshiaki Okumura, Susumu Ookawara, Yoshiyuki Morishita   +4 more
doaj   +1 more source

SARS-CoV-2 Spike and Nucleocapsid Antibody Response in Vaccinated Croatian Healthcare Workers and Infected Hospitalized Patients: A Single Center Cohort Study

Viruses, 2022
Studies assessing the dynamics and duration of antibody responses following SARS-CoV-2 infection or vaccination are an invaluable tool for vaccination schedule planning, assessment of risk groups and management of pandemics.
Paola Kučan Brlić, Martina Pavletić, Mate Lerga, Fran Krstanović, Marina Pribanić Matešić, Karmela Miklić, Suzana Malić, Leonarda Mikša, Maja Pajcur, Dolores Peruč, Maren Schubert, Federico Bertoglio, Jurica Arapović, Alen Protić, Alan Šustić, Marko Milošević, Luka Čičin Šain, Stipan Jonjić, Vanda Juranić Lisnić, Ilija Brizić   +19 more
doaj   +1 more source